Hip / Osteoarthritis / Class IV Laser / VAS+HOOS JR

This Circle helps physicians capture and monetize real-world data from their everyday delivery of Laser for Hip Osteoarthritis.

The Laser Therapy market is valued at 5.22 Billion in 2024, and is estimated to grow to over 11 billion by 2032. In terms of prevalence, hip osteoarthritis is the third most common of adult men and women. Manufacturers will thus increasingly spend on obtaining and maintaining regulatory approvals for marketing those products for Hip Osteoarthritis. Increasingly, that spending will be focused on licensing real-world safety and efficacy data from their everyday customers.

This Circle helps physicians obtain and aggregate those high quality real-world data those companies are looking for. Participation is minimally burdensome, and members will receive recurring license fees once obtained and in accordance with their contribution of Hip OA cases, outcomes and other case data.